NEWS 2024
The FHU INOVPAIN 2.0 participates in the organization of the 19th Symposium of the French Pain Research Network - Faculty of Sciences - Grand Château - April 12 and 13, 2024 - Nice
Latest events
BRAIN WEEK 2024:
FHU INOVPAIN 2.0 at the 7th Brain & Health day on Monday March 11th at the Amphitheatre Le Galet, Hôpital Pasteur 2, Nice
------------
Meeting INOVPAIN 2.0
Meeting of the clinical and academic teams of the FHU INOVPAIN 2.0.
Presentation of work and workshops.
Friday October 27
Institute of Molecular and Cellular Pharmacology
Sophia-Antipolis
Annual meeting of the URC Neurosciences of Nice University Hospital - October 26, 2023 - Pasteur Hospital 2 - Le Galet
Organized by the URC Neurosciences of Nice University Hospital and 2 teams from UR2CA (PIN and URRIS) with presentation of the results obtained and/or published this year and current projects.
- Michel Lanteri-Minet: One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: Results of the French FHU INOVPAIN Registry study
- Aurélie Leplus-Wuertzer: Somatotopy of the somatosensory thalamus: inputs from directional - deep brain stimulation in patients with refractory neuropathic pain
- Fabien Almairac: Identifying subcortical connectivity during brain tumor surgery: a multimodal study
- Denys Fontaine: Machine learning-based automated facial expression analysis to predict acute pain intensity.
Congratulations!
Dr. Jules Henri wins the Silver Medal for his medical thesis on the
Study of severe migraine in general medicine".
Award ceremony on Thursday, October 12, 2023 at the Marseille Faculty of Medicine
(Aix-Marseille University)
2020 MEDICINE AWARDS
Congratulations to Corinne Martin and Katia Pradat-Guillon, who had the privilege of receiving a trophy at the Palmes de la Médecine 2020 presentation, organized by COTE MAGAZINE, on June 17, 2021.
For years, our two nurses from pain assessment and treatment department at the Nice University Hospital are an essential link in the treatment of patients by neurostimulation, one of the flagship therapies developed within the FHU to relieve patients suffering from chronic pain that is difficult to treat.
